Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07188389 · ClinicalTrials.gov registry record · NA

Immunometabolism of Exercise

A NA study, sponsored by University of Houston.

Completed
Registry status
NA
Development phase
102
Enrollment target

NCT07188389: Completed NA study, sponsored by University of Houston.

NCT07188389 is a NA study that has completed, run by University of Houston. The registered enrollment target is 102 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07188389, a NA study, has completed, sponsored by University of Houston.

COMPLETED
Registry status
NA
Development phase
102 participants
Enrollment target

Study Summary

This study aims to examine the effects of acute aerobic exercise and cardiorespiratory fitness on cellular metabolism of CD8+ T cells and regulatory T cells (Tregs) found in the peripheral blood of humans. In addition, the study will investigate whether the effects of exercise differ based on exercise intensity, as well as whether the effects of exercise and fitness differ between subpopulations of CD8+ T cells and Tregs. Finally, the study aims to examine whether exercise- and fitness-induced changes in cell metabolism relate to changes in cell function.

Primary Outcome

Cellular metabolic activity and poise of T cells as measured by flow cytometry (SCENITH)

Interventions

  • BEHAVIORAL Acute exercise-moderate intensity
  • BEHAVIORAL Acute effects-heavy intensity

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2024-03-01
Est. Completion 2025-04-03
Phase NA
University of Houston

64 total trials

What the finished NCT07188389 record still lists

NCT07188389 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Acute exercise-moderate intensity is the first listed.

NCT07188389 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07188389 about?

NCT07188389 is a clinical study titled "Immunometabolism of Exercise". This study aims to examine the effects of acute aerobic exercise and cardiorespiratory fitness on cellular metabolism of CD8+ T cells and regulatory T cells (Tregs) found in the peripheral blood of humans. In addition, the study will investigate whether the effects of exercise differ based on exerci...

What is the current status of trial NCT07188389?

This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2024-03-01. Estimated completion is 2025-04-03.

What interventions are being tested in trial NCT07188389?

The interventions under investigation include: Acute exercise-moderate intensity (BEHAVIORAL), Acute effects-heavy intensity (BEHAVIORAL).

Who is sponsoring clinical trial NCT07188389?

This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07188389's enrollment target sits among peer trials

102 837th of 2000 higher than 1,161 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03704662 · 102 participants · NA

    Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

  • NCT04174742 · 102 participants

    Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

  • NCT04275362 · 102 participants

    Gait Analysis of a Lateral-Pivot Design Total Knee Replacement

  • NCT04541082 · 102 participants · Phase 1

    Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07188389, the US trial registry maintained by the National Library of Medicine. NCT07188389 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.